Inhibition of hypoxia inducible factor 1-transcription coactivator interaction by a hydrogen bond surrogate α-helix

Laura K. Henchey, Swati Kushal, Ramin Dubey, Ross N. Chapman, Bogdan Z. Olenyuk, Paramjit Arora

Research output: Contribution to journalArticle

Abstract

(Chemical Equation Presented) Designed ligands that inhibit hypoxia-inducible gene expression could offer new tools for genomic research and, potentially, drug discovery efforts for the treatment of neovascularization in cancers. We report a stabilizedα-helix designed to target the binding interface between the C-terminal transactivation domain (C-TAD) of hypoxia-inducible factor 1α (HIF-1α) and cysteine-histidine rich region (CH1) of transcriptional coactivator CBP/p300. The synthetic helix disrupts the structure and function of this complex, resulting in a rapid downregulation of two hypoxia-inducible genes (VEGF and GLUT1) in cell culture.

Original languageEnglish (US)
Pages (from-to)941-943
Number of pages3
JournalJournal of the American Chemical Society
Volume132
Issue number3
DOIs
StatePublished - 2010

Fingerprint

p300-CBP Transcription Factors
Hypoxia-Inducible Factor 1
Transcription
Cell culture
Histidine
Gene expression
Vascular Endothelial Growth Factor A
Cysteine
Hydrogen
Hydrogen bonds
Genes
Ligands
Drug Discovery
Transcriptional Activation
Down-Regulation
Cell Culture Techniques
Gene Expression
Research
Neoplasms
Hypoxia

ASJC Scopus subject areas

  • Chemistry(all)
  • Catalysis
  • Biochemistry
  • Colloid and Surface Chemistry

Cite this

Inhibition of hypoxia inducible factor 1-transcription coactivator interaction by a hydrogen bond surrogate α-helix. / Henchey, Laura K.; Kushal, Swati; Dubey, Ramin; Chapman, Ross N.; Olenyuk, Bogdan Z.; Arora, Paramjit.

In: Journal of the American Chemical Society, Vol. 132, No. 3, 2010, p. 941-943.

Research output: Contribution to journalArticle

Henchey, Laura K. ; Kushal, Swati ; Dubey, Ramin ; Chapman, Ross N. ; Olenyuk, Bogdan Z. ; Arora, Paramjit. / Inhibition of hypoxia inducible factor 1-transcription coactivator interaction by a hydrogen bond surrogate α-helix. In: Journal of the American Chemical Society. 2010 ; Vol. 132, No. 3. pp. 941-943.
@article{2515572773d94cd6b3d64b4452320a22,
title = "Inhibition of hypoxia inducible factor 1-transcription coactivator interaction by a hydrogen bond surrogate α-helix",
abstract = "(Chemical Equation Presented) Designed ligands that inhibit hypoxia-inducible gene expression could offer new tools for genomic research and, potentially, drug discovery efforts for the treatment of neovascularization in cancers. We report a stabilizedα-helix designed to target the binding interface between the C-terminal transactivation domain (C-TAD) of hypoxia-inducible factor 1α (HIF-1α) and cysteine-histidine rich region (CH1) of transcriptional coactivator CBP/p300. The synthetic helix disrupts the structure and function of this complex, resulting in a rapid downregulation of two hypoxia-inducible genes (VEGF and GLUT1) in cell culture.",
author = "Henchey, {Laura K.} and Swati Kushal and Ramin Dubey and Chapman, {Ross N.} and Olenyuk, {Bogdan Z.} and Paramjit Arora",
year = "2010",
doi = "10.1021/ja9082864",
language = "English (US)",
volume = "132",
pages = "941--943",
journal = "Journal of the American Chemical Society",
issn = "0002-7863",
publisher = "American Chemical Society",
number = "3",

}

TY - JOUR

T1 - Inhibition of hypoxia inducible factor 1-transcription coactivator interaction by a hydrogen bond surrogate α-helix

AU - Henchey, Laura K.

AU - Kushal, Swati

AU - Dubey, Ramin

AU - Chapman, Ross N.

AU - Olenyuk, Bogdan Z.

AU - Arora, Paramjit

PY - 2010

Y1 - 2010

N2 - (Chemical Equation Presented) Designed ligands that inhibit hypoxia-inducible gene expression could offer new tools for genomic research and, potentially, drug discovery efforts for the treatment of neovascularization in cancers. We report a stabilizedα-helix designed to target the binding interface between the C-terminal transactivation domain (C-TAD) of hypoxia-inducible factor 1α (HIF-1α) and cysteine-histidine rich region (CH1) of transcriptional coactivator CBP/p300. The synthetic helix disrupts the structure and function of this complex, resulting in a rapid downregulation of two hypoxia-inducible genes (VEGF and GLUT1) in cell culture.

AB - (Chemical Equation Presented) Designed ligands that inhibit hypoxia-inducible gene expression could offer new tools for genomic research and, potentially, drug discovery efforts for the treatment of neovascularization in cancers. We report a stabilizedα-helix designed to target the binding interface between the C-terminal transactivation domain (C-TAD) of hypoxia-inducible factor 1α (HIF-1α) and cysteine-histidine rich region (CH1) of transcriptional coactivator CBP/p300. The synthetic helix disrupts the structure and function of this complex, resulting in a rapid downregulation of two hypoxia-inducible genes (VEGF and GLUT1) in cell culture.

UR - http://www.scopus.com/inward/record.url?scp=76149106544&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76149106544&partnerID=8YFLogxK

U2 - 10.1021/ja9082864

DO - 10.1021/ja9082864

M3 - Article

VL - 132

SP - 941

EP - 943

JO - Journal of the American Chemical Society

JF - Journal of the American Chemical Society

SN - 0002-7863

IS - 3

ER -